Output list
Editorial
Economic evaluation for pharmaceuticals in Germany
Published 2007-09-01
The European Journal of Health Economics, 8, 1, S1 - S2
Editorial
A global comparison regarding patient access to cancer drugs - Preface
Published 2007-01-01
Annals of Oncology, 18, 3, 1 - 1
Editorial
Time for a Common Standard for Cost-Effectiveness in Europe?
Published 2006-12-01
The European Journal of Health Economics, 7, 4, 223 - 224
Editorial
The cost of multiple sclerosis in Europe
Published 2006-07
The European Journal of Health Economics, 7, 2, 3 - 4
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system with onset in the early thirties. The disease is characterized by inflammation, destruction of the myelin coating of nerve fibres and axonal loss that lead to symptoms such as visual and sensory disturbances, limb weakness, gait problems and neurogenic bladder and bowel symptoms, all of which become increasingly disabling over time. Irreversible functional disability occurs early, making MS the second most common cause of neurological disability in young adults.
Editorial
Economic evaluation of interventions for osteoporosis
Published 2002-10-01
Osteoporosis international, 13, 10, 765 - 767
Editorial
Published 2002
PharmacoEconomics, 20, Suppl. 1, X